Antibiotic Development: US FDA Needs Draft Guidance On QIDP Designation, GAO Says

Sponsors lack comprehensive advice on how to access benefits of GAIN legislation's incentives, which include the opportunity for fast track designation, priority review designation and five years of market exclusivity, government watchdog says.